Staffing & Employment Services
Compare Stocks
3 / 10Stock Comparison
TNET vs PAYX vs INSP
Revenue, margins, valuation, and 5-year total return — side by side.
Staffing & Employment Services
Medical - Devices
TNET vs PAYX vs INSP — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Staffing & Employment Services | Staffing & Employment Services | Medical - Devices |
| Market Cap | $1.98B | $33.84B | $1.31B |
| Revenue (TTM) | $4.94B | $6.03B | $915M |
| Net Income (TTM) | $159M | $1.60B | $131M |
| Gross Margin | 17.7% | 73.4% | 85.8% |
| Operating Margin | 5.5% | 37.1% | 5.6% |
| Forward P/E | 10.1x | 17.2x | 24.5x |
| Total Debt | $979M | $5.02B | $32M |
| Cash & Equiv. | $1.98B | $1.63B | $105M |
TNET vs PAYX vs INSP — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| TriNet Group, Inc. (TNET) | 100 | 79.8 | -20.2% |
| Paychex, Inc. (PAYX) | 100 | 130.4 | +30.4% |
| Inspire Medical Sys… (INSP) | 100 | 55.9 | -44.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TNET vs PAYX vs INSP
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TNET is the clearest fit if your priority is long-term compounding.
- 147.4% 10Y total return vs PAYX's 135.4%
- Lower P/E (10.1x vs 24.5x)
PAYX carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 14 yrs, beta 0.39, yield 4.2%
- Lower volatility, beta 0.39, current ratio 1.28x
- Beta 0.39, yield 4.2%, current ratio 1.28x
INSP is the clearest fit if your priority is growth exposure.
- Rev growth 13.6%, EPS growth 179.4%, 3Y rev CAGR 30.8%
- 13.6% revenue growth vs TNET's -0.9%
- 15.2% ROA vs TNET's 4.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 13.6% revenue growth vs TNET's -0.9% | |
| Value | Lower P/E (10.1x vs 24.5x) | |
| Quality / Margins | 26.4% margin vs TNET's 3.2% | |
| Stability / Safety | Beta 0.39 vs INSP's 1.27 | |
| Dividends | 4.2% yield, 14-year raise streak, vs TNET's 2.5%, (1 stock pays no dividend) | |
| Momentum (1Y) | -34.4% vs INSP's -70.9% | |
| Efficiency (ROA) | 15.2% ROA vs TNET's 4.4% |
TNET vs PAYX vs INSP — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
TNET vs PAYX vs INSP — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
PAYX leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PAYX is the larger business by revenue, generating $6.0B annually — 6.6x INSP's $915M. PAYX is the more profitable business, keeping 26.4% of every revenue dollar as net income compared to TNET's 3.2%. On growth, PAYX holds the edge at +18.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $4.9B | $6.0B | $915M |
| EBITDAEarnings before interest/tax | $372M | $2.6B | $62M |
| Net IncomeAfter-tax profit | $159M | $1.6B | $131M |
| Free Cash FlowCash after capex | $330M | $2.1B | $97M |
| Gross MarginGross profit ÷ Revenue | +17.7% | +73.4% | +85.8% |
| Operating MarginEBIT ÷ Revenue | +5.5% | +37.1% | +5.6% |
| Net MarginNet income ÷ Revenue | +3.2% | +26.4% | +14.3% |
| FCF MarginFCF ÷ Revenue | +6.7% | +34.1% | +10.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -5.1% | +18.3% | +1.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +10.5% | -3.5% | -5.0% |
Valuation Metrics
TNET leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 9.3x trailing earnings, INSP trades at a 55% valuation discount to PAYX's 20.6x P/E. On an enterprise value basis, TNET's 2.8x EV/EBITDA is more attractive than INSP's 19.1x.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $2.0B | $33.8B | $1.3B |
| Enterprise ValueMkt cap + debt − cash | $976M | $37.2B | $1.2B |
| Trailing P/EPrice ÷ TTM EPS | 13.57x | 20.58x | 9.32x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.07x | 17.15x | 24.46x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.41x | — |
| EV / EBITDAEnterprise value multiple | 2.77x | 15.40x | 19.11x |
| Price / SalesMarket cap ÷ Revenue | 0.39x | 6.07x | 1.44x |
| Price / BookPrice ÷ Book value/share | 38.12x | 8.27x | 1.74x |
| Price / FCFMarket cap ÷ FCF | 6.46x | 19.23x | 16.73x |
Profitability & Efficiency
INSP leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
TNET delivers a 179.7% return on equity — every $100 of shareholder capital generates $180 in annual profit, vs $18 for INSP. INSP carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to TNET's 18.13x. On the Piotroski fundamental quality scale (0–9), INSP scores 7/9 vs PAYX's 5/9, reflecting strong financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +179.7% | +41.1% | +18.0% |
| ROA (TTM)Return on assets | +4.4% | +9.7% | +15.2% |
| ROICReturn on invested capital | — | +30.9% | +6.0% |
| ROCEReturn on capital employed | +23.2% | +30.1% | +6.7% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 7 |
| Debt / EquityFinancial leverage | 18.13x | 1.22x | 0.04x |
| Net DebtTotal debt minus cash | -$1.0B | $3.4B | -$73M |
| Cash & Equiv.Liquid assets | $2.0B | $1.6B | $105M |
| Total DebtShort + long-term debt | $979M | $5.0B | $32M |
| Interest CoverageEBIT ÷ Interest expense | 5.20x | 10.38x | 418.58x |
Total Returns (Dividends Reinvested)
PAYX leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PAYX five years ago would be worth $11,074 today (with dividends reinvested), compared to $2,342 for INSP. Over the past 12 months, PAYX leads with a -34.4% total return vs INSP's -70.9%. The 3-year compound annual growth rate (CAGR) favors PAYX at -0.1% vs INSP's -45.6% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | -24.0% | -12.2% | -50.6% |
| 1-Year ReturnPast 12 months | -45.7% | -34.4% | -70.9% |
| 3-Year ReturnCumulative with dividends | -50.1% | -0.3% | -83.9% |
| 5-Year ReturnCumulative with dividends | -44.6% | +10.7% | -76.6% |
| 10-Year ReturnCumulative with dividends | +147.4% | +135.4% | +82.4% |
| CAGR (3Y)Annualised 3-year return | -20.7% | -0.1% | -45.6% |
Risk & Volatility
PAYX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
PAYX is the less volatile stock with a 0.39 beta — it tends to amplify market swings less than INSP's 1.27 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PAYX currently trades 58.5% from its 52-week high vs INSP's 27.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.83x | 0.39x | 1.27x |
| 52-Week HighHighest price in past year | $86.78 | $161.24 | $163.35 |
| 52-Week LowLowest price in past year | $33.60 | $85.45 | $44.41 |
| % of 52W HighCurrent price vs 52-week peak | +49.4% | +58.5% | +27.9% |
| RSI (14)Momentum oscillator 0–100 | 51.3 | 48.0 | 31.6 |
| Avg Volume (50D)Average daily shares traded | 433K | 3.9M | 1.1M |
Analyst Outlook
PAYX leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: TNET as "Hold", PAYX as "Hold", INSP as "Hold". Consensus price targets imply 100.4% upside for INSP (target: $91) vs 19.0% for PAYX (target: $112). For income investors, PAYX offers the higher dividend yield at 4.25% vs TNET's 2.53%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $68.50 | $112.14 | $91.33 |
| # AnalystsCovering analysts | 14 | 30 | 27 |
| Dividend YieldAnnual dividend ÷ price | +2.5% | +4.2% | — |
| Dividend StreakConsecutive years of raises | 1 | 14 | — |
| Dividend / ShareAnnual DPS | $1.08 | $4.00 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +9.3% | +0.3% | +13.3% |
PAYX leads in 4 of 6 categories (Income & Cash Flow, Total Returns). TNET leads in 1 (Valuation Metrics).
TNET vs PAYX vs INSP: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is TNET or PAYX or INSP a better buy right now?
For growth investors, Inspire Medical Systems, Inc.
(INSP) is the stronger pick with 13. 6% revenue growth year-over-year, versus -0. 9% for TriNet Group, Inc. (TNET). Inspire Medical Systems, Inc. (INSP) offers the better valuation at 9. 3x trailing P/E (24. 5x forward), making it the more compelling value choice. Analysts rate TriNet Group, Inc. (TNET) a "Hold" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TNET or PAYX or INSP?
On trailing P/E, Inspire Medical Systems, Inc.
(INSP) is the cheapest at 9. 3x versus Paychex, Inc. at 20. 6x. On forward P/E, TriNet Group, Inc. is actually cheaper at 10. 1x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — TNET or PAYX or INSP?
Over the past 5 years, Paychex, Inc.
(PAYX) delivered a total return of +10. 7%, compared to -76. 6% for Inspire Medical Systems, Inc. (INSP). Over 10 years, the gap is even starker: TNET returned +147. 4% versus INSP's +82. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TNET or PAYX or INSP?
By beta (market sensitivity over 5 years), Paychex, Inc.
(PAYX) is the lower-risk stock at 0. 39β versus Inspire Medical Systems, Inc. 's 1. 27β — meaning INSP is approximately 227% more volatile than PAYX relative to the S&P 500. On balance sheet safety, Inspire Medical Systems, Inc. (INSP) carries a lower debt/equity ratio of 4% versus 18% for TriNet Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — TNET or PAYX or INSP?
By revenue growth (latest reported year), Inspire Medical Systems, Inc.
(INSP) is pulling ahead at 13. 6% versus -0. 9% for TriNet Group, Inc. (TNET). On earnings-per-share growth, the picture is similar: Inspire Medical Systems, Inc. grew EPS 179. 4% year-over-year, compared to -7. 9% for TriNet Group, Inc.. Over a 3-year CAGR, INSP leads at 30. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TNET or PAYX or INSP?
Paychex, Inc.
(PAYX) is the more profitable company, earning 29. 7% net margin versus 3. 1% for TriNet Group, Inc. — meaning it keeps 29. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PAYX leads at 39. 6% versus 5. 3% for TNET. At the gross margin level — before operating expenses — INSP leads at 85. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TNET or PAYX or INSP more undervalued right now?
On forward earnings alone, TriNet Group, Inc.
(TNET) trades at 10. 1x forward P/E versus 24. 5x for Inspire Medical Systems, Inc. — 14. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for INSP: 100. 4% to $91. 33.
08Which pays a better dividend — TNET or PAYX or INSP?
In this comparison, PAYX (4.
2% yield), TNET (2. 5% yield) pay a dividend. INSP does not pay a meaningful dividend and should not be held primarily for income.
09Is TNET or PAYX or INSP better for a retirement portfolio?
For long-horizon retirement investors, Paychex, Inc.
(PAYX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 39), 4. 2% yield, +135. 4% 10Y return). Both have compounded well over 10 years (PAYX: +135. 4%, INSP: +82. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TNET and PAYX and INSP?
These companies operate in different sectors (TNET (Industrials) and PAYX (Industrials) and INSP (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: TNET is a small-cap deep-value stock; PAYX is a mid-cap income-oriented stock; INSP is a small-cap deep-value stock. TNET, PAYX pay a dividend while INSP does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.